Intelligent Bio Solutions (INBS) Payables (2020 - 2025)

Intelligent Bio Solutions has reported Payables for 6 years, with the latest figure at $4.7 million in Q2 2025.

• For the quarter ending Q2 2025, Payables rose 113.14% year-over-year to $4.7 million; the trailing twelve-month figure through Jun 2025 stood at $4.7 million (up 113.14% YoY), and the FY2025 full-year result was $4.7 million, up 113.14% from the prior year.
• Payables for Q2 2025 stood at $4.7 million, up from $1.7 million in the prior quarter.
• The five-year high for Payables was $4.7 million in Q2 2025, with the low at $448886.0 in Q4 2021.
• Average Payables over 5 years is $1.9 million, with a median of $1.7 million recorded in 2022.
• Peak annual rise in Payables reached 430.02% in 2022, while the deepest fall reached 41.9% in 2022.
• Tracing INBS's Payables over 5 years: stood at $448886.0 in 2021, then jumped by 430.02% to $2.4 million in 2022, then dropped by 10.32% to $2.1 million in 2023, then slumped by 30.62% to $1.5 million in 2024, then surged by 219.63% to $4.7 million in 2025.
• The last three Payables figures came in at $4.7 million (Q2 2025), $1.7 million (Q1 2025), and $1.5 million (Q4 2024), per Business Quant data.

Peer Comparison